Evidence map›Paper›PMID 42798713›Full record

ArticleO&G open2026

Cumulative Incidence of Venous Thromboembolism in Patients With Uterine Cancer.

Dib Sassine, Ling Chen, Xiao Xu, Jennifer S Ferris, Dawn L Hershman, Jason D Wright, June Y Hou

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in O&G open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Dib SassineDepartment of Obstetrics and Gynecology and Department of Medicine, College of Physicians and Surgeons, and Joseph L. Mailman School of Public Health, Columbia University, New York, New York; Department of Obstetrics and Gynecology, Tufts Medical Center, Boston, Massachusetts; Herbert Irving Comprehensive Cancer Center, New York, New York; and New York-Presbyterian Hospital, New York, New York.
Ling ChenDepartment of Obstetrics and Gynecology and Department of Medicine, College of Physicians and Surgeons, and Joseph L. Mailman School of Public Health, Columbia University, New York, New York; Department of Obstetrics and Gynecology, Tufts Medical Center, Boston, Massachusetts; Herbert Irving Comprehensive Cancer Center, New York, New York; and New York-Presbyterian Hospital, New York, New York.
Xiao XuDepartment of Obstetrics and Gynecology and Department of Medicine, College of Physicians and Surgeons, and Joseph L. Mailman School of Public Health, Columbia University, New York, New York; Department of Obstetrics and Gynecology, Tufts Medical Center, Boston, Massachusetts; Herbert Irving Comprehensive Cancer Center, New York, New York; and New York-Presbyterian Hospital, New York, New York.
Jennifer S FerrisDepartment of Obstetrics and Gynecology and Department of Medicine, College of Physicians and Surgeons, and Joseph L. Mailman School of Public Health, Columbia University, New York, New York; Department of Obstetrics and Gynecology, Tufts Medical Center, Boston, Massachusetts; Herbert Irving Comprehensive Cancer Center, New York, New York; and New York-Presbyterian Hospital, New York, New York.
Dawn L HershmanDepartment of Obstetrics and Gynecology and Department of Medicine, College of Physicians and Surgeons, and Joseph L. Mailman School of Public Health, Columbia University, New York, New York; Department of Obstetrics and Gynecology, Tufts Medical Center, Boston, Massachusetts; Herbert Irving Comprehensive Cancer Center, New York, New York; and New York-Presbyterian Hospital, New York, New York.
Jason D WrightDepartment of Obstetrics and Gynecology and Department of Medicine, College of Physicians and Surgeons, and Joseph L. Mailman School of Public Health, Columbia University, New York, New York; Department of Obstetrics and Gynecology, Tufts Medical Center, Boston, Massachusetts; Herbert Irving Comprehensive Cancer Center, New York, New York; and New York-Presbyterian Hospital, New York, New York.
June Y HouDepartment of Obstetrics and Gynecology and Department of Medicine, College of Physicians and Surgeons, and Joseph L. Mailman School of Public Health, Columbia University, New York, New York; Department of Obstetrics and Gynecology, Tufts Medical Center, Boston, Massachusetts; Herbert Irving Comprehensive Cancer Center, New York, New York; and New York-Presbyterian Hospital, New York, New York.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Using the Surveillance, Epidemiology, and End Results (SEER)-Medicare database, we identified women 65 years of age and older diagnosed with uterine cancer between 2008 and 2017 to evaluate the cumulative incidence of venous thromboembolism (VTE). Patients were followed from 6 months before to up to 10 years after diagnosis. A total of 683 patients with prevalent VTE (within 6 months before cancer diagnosis) were excluded. Among the remaining 25,204 patients with a median age of 72 years, 4,907 (19.5%) had VTE events during the follow-up period. The 10-year cumulative incidence of VTE increased with stage at diagnosis: 23.1% (95% CI 22.1-24.1%) for localized, 38.9% (95% CI 36.8-40.9%) for regional, and 56.5% (95% 51.0-61.7%) for distant disease. Our findings indicate a substantial and persistent thrombotic burden, particularly for patients with advanced-stage uterine cancer.

Identifiers

PMID42798713
PMCPMC13612810

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.